24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
63.16% |
|
IL 2 FORCE FIELD BENCHMARKING |
31.58% |
|
ANTIBODY DYNAMICS SIMULATION |
5.26% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
37.82% |
|
ANTIBODY DYNAMICS SIMULATION |
31.09% |
|
IL 2 FORCE FIELD BENCHMARKING |
10.92% |
|
PARKINSONS |
10.08% |
|
IL 2 DYNAMICS SIMULATIONS |
10.08% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
21.83% |
|
ANTIBODY DYNAMICS SIMULATION |
19.44% |
|
ANTIBODY DYNAMICS |
14.13% |
|
IL 2 FORCE FIELD BENCHMARKING |
10.25% |
|
ANTIBODY AFFINITY MATURATION |
9.57% |
|
IL 2 DYNAMICS SIMULATIONS |
8.26% |
|
IL 2 RECEPTOR DYNAMICS |
6.39% |
|
ALZHEIMERS |
4.38% |
|
STP6 SUGAR TRANSPORT |
1.75% |
|
PARKINSONS |
1.08% |
|
ATSTP10 SUCROSE TRANSPORT |
.9% |
|
SUCROSE TRANSPORT PLANTS |
.7% |
|
UNSPECIFIED |
.55% |
|
MEMBRANE TRANSPORT |
.35% |
|
PLANT SUCROSE TRANSPORT |
.29% |
|
CANCER |
.12% |